Notification of Major Interest in Shares

RNS Number : 4276I

Alliance Pharma PLC

08 December 2015

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Alliance Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments				√
An event changing the breakdown of voting rights
Other (please specify):	Change in nature: Shares loaned out.			√
3. Full name of person(s) subject to the notification obligation:		Aviva plc & its subsidiaries
4. Full name of shareholder(s)  (if different from 3.):		Registered Holder: BNY Norwich Union Nominees Limited      2,377,360*                                                               Chase (GA Group) Nominees Limited       17,925,913* *denotes direct interest Chase Nominees Limited                                730,258
5. Date of the transaction and date on which the threshold is crossed or reached:		04 December 2015
6. Date on which issuer notified:		07 December 2015
7. Threshold(s) that is/are crossed or reached:		8% to 7% Change at Direct Interest Level

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction				Resulting situation after the triggering transaction
	Number of Shares		Number of Voting Rights		Number of shares	Number of voting rights			% of  voting rights
					Direct	Direct		Indirect	Direct		Indirect
Ordinary Shares GB0031030819	24,085,876		24,085,876		21,033,531	20,303,273		730,258	7.68%		0.27%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Expiration date		Exercise/ Conversion Period			Number of voting rights that may be acquired if the instrument is exercised/ converted.			% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date	Exercise/ Conversion period	Number of voting rights instrument refers to	% of voting rights
RIGHT TO RECALL LOANED SHARES	N/A	N/A	N/A	1,500,000* *Direct Interest	Nominal	Delta
					0.57%

Total (A+B+C)
Number of voting rights	Percentage of voting rights
22,533,531	8.52%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: ·      Aviva plc (Parent Company) ·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) ·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
10. Name of the proxy holder:		See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Figures are based on a total number of voting rights of  264,520,610 as per the Company's Exercise of Share Options Announcement of 21 August 2015.
14. Contact name:	Neil Whittaker, Aviva plc
15. Contact telephone number:	01603 684420

 

END

 

 

HOLEAXAPEDNSFFF